Publication & Citation Trends
Publications
174 total
G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer PDF
Cited by 168
OpenAlex
Estradiol and Progesterone Regulate the Migration of Mast Cells from the Periphery to the Uterus and Induce Their Maturation and Degranulation PDF
Cited by 146
OpenAlex
Role of GPR30 in the mechanisms of tamoxifen resistance in breast cancer MCF-7 cells PDF
Cited by 167
OpenAlex
Pegfilgrastim ± ciprofloxacin for primary prophylaxis with TAC (docetaxel/doxorubicin/cyclophosphamide) chemotherapy for breast cancer. Results from the GEPARTRIO study
Cited by 150
OpenAlex
Randomized Phase III Trial of Topotecan Following Carboplatin and Paclitaxel in First-line Treatment of Advanced Ovarian Cancer: A Gynecologic Cancer Intergroup Trial of the AGO-OVAR and GINECO
Cited by 209
OpenAlex
Addition of Epirubicin As a Third Drug to Carboplatin-Paclitaxel in First-Line Treatment of Advanced Ovarian Cancer: A Prospectively Randomized Gynecologic Cancer Intergroup Trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group and the Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens PDF
Cited by 196
OpenAlex
Research Topics
Breast Cancer Treatment Studies
(72)
Cancer Treatment and Pharmacology
(40)
HER2/EGFR in Cancer Research
(38)
Breast Lesions and Carcinomas
(24)
Ovarian cancer diagnosis and treatment
(22)
Affiliations
Goethe University Frankfurt
German Cancer Research Center
Friedrich-Alexander-Universität Erlangen-Nürnberg
Heidelberg University
Universidade Federal de Pernambuco